China contract development and manufacturing organization (CDMO) WuXi STA has agreed to buy Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland, for an...
Through a subsidiary, Shanghai, China-based WuXi Biologics (WuXi Bio) is acquiring Bayer’s biologics substance plant at Wuppertal, Germany, for €150 million ($183.3...
22.01.2020
- Shanghai, China-based Wuxi Biologics has taken a long lease on one of Bayer’s finished drug plants at Leverkusen, Germany, and will buy the plant’s equipment. The facility’s 24...
09.05.2019
- Clariant and Chinese engineering partner Wuxi Xiyuan have won contracts to supply their joint formaldehyde technology for two new plants in China. The deals, said Clariant, take...
